Open RFP

Generative Unconstrained Intelligence Drug Engineering (GUIDE) collaboration between U.S. interagency, academic and industry partners

Description: The GUIDE program uses computational and experimental methods, including advanced simulation and machine learning, to accelerate medical countermeasure development. It seeks to improve discovery and design of biological products and small-molecule drugs while optimizing safety, efficacy, manufacturability, and other development attributes. This special notice invites qualified entities to request participation through a Participant Basic Agreement and demonstrate relevant expertise; it is not a grant program, and the notice makes no commitment to award.

Buyer
Department of the Army

Federal · DC, US

Released
Oct 18, 2024
Closes
Oct 18, 2028(720 days left)
See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.
See your top 10 accounts